Mass spectrometry – our new study reveals trends, R&D progress, and predicted revenues Where is the mass spectrometry market heading? If you are involved in this sector you must read this brand new report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead Our 183-page report provides 111 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, interviews, trends, opportunities, and revenue predictions. Much opportunity remains in this growing mass spectrometry market. See how to exploit the opportunities.
Forecasts to 2027 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares. • You find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets Along with revenue prediction for the overall world market and 4 different segmentations, with 2 device types, 6 technologies and 7 applications
• Mass Spectrometry Device Market Forecasts to 2027, By Technology:
– Single • Ion Trap Mass Spectrometry • Quadrupole Mass Spectrometry • Time-of-Flight Mass Spectrometry
– Hybrid • Triple Quadrupole Mass Spectrometry • Quadrupole-TOF Mass Spectrometry • Fourier Transform Mass Spectrometry
• Mass Spectrometry Market Forecasts to 2027, By Application: – Academia – Biotech and Biopharma – Agriculture – Contract Research Organisations – Hospitals/ Clinical Laboratories – Environmental Industry – Materials Industry
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 12 leading national markets:
• North America – US – Canada
• Europe – Germany – France – UK – Italy – Spain
• APAC – Japan – China – India – Australia & New Zealand
• Rest of the World
The report also includes profiles and forecasts for some of the leading companies in the mass spectrometry device market, with a focus on the mass spectrometry device segment of these companies’ operations.
There will be growth in both established and in developing countries. Our analyses show that the developing markets, China and India in particular, will continue to achieve high revenue growth to 2027. Developments worldwide in medical device regulation, especially in the US and Japan will influence the market.
Leading companies and the potential for market growth Overall world revenue for mass spectrometry will surpass $3.8bn in 2017, our work calculates. We predict strong revenue growth through to 2027. Market entry of continuous mass spectrometry devices and increasing prevalence of neurological conditions will increase sales to 2027.
Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Mass Spectrometry Market report helps you In summary, our 183-page report provides you with the following knowledge: • Revenue forecasts to 2027 for the world mass spectrometry market and 3 different segmentations, with 2 device types, 6 product categories and 7 applications – discover the industry’s prospects, finding the most lucrative places for investments and revenues • Revenue forecasts to 2027 for 4 regional markets and 12 of the leading national markets – North America: US, Canada, Europe: Germany, UK, France, Italy, Spain & Rest of Europe, APAC: Japan, China, Australia & New Zealand, India, & Rest of APAC and the Rest of the World • Discussion of what stimulates and restrains companies and the market • Prospects for established firms and those seeking to enter the market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.
Visiongain’s study is for everybody needing commercial analyses for the mass spectrometry device market and leading companies. You find data, trends and predictions.
Get our report today The Mass Spectrometry Market Forecast 2017-2027: Revenue Prospects by Technology (Single, Ion Trap, Quadrupole, Hybrid, Triple Quadrupole, Q-TOF, FTMS), by Application (Academia, Biotech, Agriculture, CRO, Hospitals, Environmental, Materials) and Geography. Avoid missing out – get our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview 1.1 Global Mass Spectrometry Market Overview 1.2 Why You Should Read This Report 1.3 How This Report Delivers 1.4 Key Questions Answered by This Analytical Report Include: 1.5 Who is This Report For? 1.6 Methodology 1.6.1 Primary Research 1.6.2 Secondary Research 1.6.3 Market Evaluation & Forecasting Methodology 1.7 Frequently Asked Questions (FAQ) 1.8 Associated Visiongain Reports 1.9 About Visiongain
2. Introduction to the Mass Spectrometry Market 2.1 Mass Spectrometry Market Structure 2.2 Overview of Findings 2.3 Introduction to Mass Spectrometry 2.3.1 Single Mass Spectrometry 2.3.2 Hybrid Mass Spectrometry 2.3.3 Mass Spectrometry in Academic Research 2.3.4 Mass Spectrometry in Industry 2.4 Regulation of Medical Devices 2.4.1 The US Medical Device Regulation System 2.4.2 The EU Medical Device Regulation System
3. Global Mass Spectrometry Market 2016-2027 3.1 Global Mass Spectrometry Market Forecast 2016-2027 3.2 Global Mass Spectrometry Drivers & Restraints 2016 3.2.1 Global Mass Spectrometry Market Drivers 2016 3.2.2 Global Mass Spectrometry Market Restraints 2016
4. Global Mass Spectrometry by Technology, Forecast 2016-2027 4.1 Global Single Mass Spectrometry Market Forecast 2016-2027 4.1.1 Global Ion Trap Mass Spectrometry Market 4.1.2 Global Quadrupole Mass Spectrometry Market 4.1.3 Global Time-of-Flight Mass Spectrometry Market 4.2 Global Hybrid Mass Spectrometry Market Forecast 2016-2027 4.2.1 Global Triple Quadrupole Mass Spectrometry Market Forecast 2016-2017 4.2.2 Global Quadrupole-TOF (Q-TOF) Mass Spectrometry Market Forecast 2016-2027 4.2.3 Global Fourier Transform Mass Spectrometry (FTMS) Market Forecast 2016-2027
5. Global Mass Spectrometry by Application, Forecast 2016-2027 5.1 Global Academia Mass Spectrometry Market Forecast 2016-2027 5.2 Global Biotech and Biopharma Mass Spectrometry Market Forecast 2016-2027 5.3 Global Agriculture Mass Spectrometry Market Forecast 2016-2027 5.4 Global Contract Research Organizations Mass Spectrometry Market Forecast 2016-2027 5.5 Global Hospitals/Clinical Laboratories Mass Spectrometry Market Forecast 2016-2027 5.6 Global Environmental Industry Mass Spectrometry Market Forecast 2016-2027 5.7 Global Materials Industry Mass Spectrometry Market Forecast 2016-2027
6. Leading National Markets Forecast 2016-2027 6.1 Geographical Breakdown of the Mass Spectrometry Market 6.2 Global Mass Spectrometry Market: Regional Forecast 2016-2027 6.3 The North America Mass Spectrometry Market 2016-2027 6.3.1 The US Mass Spectrometry Market 2016-2027 6.3.1.1 The US Mass Spectrometry Market Forecast 2016-2027 6.3.2 Canada Mass Spectrometry Market 2016-2027 6.3.2.1 The Canadian Mass Spectrometry Market Forecast 2016-2027 6.4 The European Mass Spectrometry Market 2016-2027 6.4.1 The European Mass Spectrometry Market Forecast 2016-2027 6.4.1.1 German Mass Spectrometry Market Forecast 2016-2027 6.4.1.2 French Mass Spectrometry Market Forecast 2016-2027 6.4.1.3 The UK Mass Spectrometry Market Forecast 2016-2027 6.4.1.4 Italian Mass Spectrometry Market Forecast 2016-2027 6.4.1.5 Spanish Mass Spectrometry Market Forecast 2016-2027 6.5 APAC Mass Spectrometry Market 2016-2027 6.5.1 APAC Mass Spectrometry Market Forecast 2016-2027 6.5.1.1 Japanese Mass Spectrometry Market Forecast 2016-2027 6.5.1.2 Chinese Mass Spectrometry Market Forecast 2016-2027 6.5.1.3 Indian Mass Spectrometry Market Forecast 2016-2027 6.5.1.4 Australia & New Zealand Mass Spectrometry Market Forecast 2016-2027
7. SWOT Analysis of the Mass Spectrometry Market 2016-2026 7.1 Strengths 7.1.1 Continuous Innovation And Product Launches 7.1.2 Collaborations And Partnerships Between Global Players And Smes Or Local Players 7.2 Weaknesses 7.2.1 High cost of Instruments 7.2.2 Requirement of Skilled Labour 7.3 Opportunities 7.3.1 Increasing Usage In Proteomics, Metabolomics And Clinical Research 7.3.2 Strict safety regulations requirement in pharmaceutical and life sciences sector 7.4 Threats 7.4.1 Intense Competition For Local Manufacturers From Increasing Presence Of Foreign Players 7.4.2 Revision Of Medical Directives In The European Region
8. Leading Companies in Mass Spectrometry Market 8.1 Agilent Technologies 8.1.1 Agilent Technologies Mass Spectrometry Product Portfolio 8.1.2 Agilent Technologies: Financial Overview 8.1.3 Agilent Technologies: Recent Development 8.1.3.1 Agilent Technologies and Burning Rock collaboration 8.1.3.2 Agilent Technologies to build new facility in Colorado 8.1.3.3 Agilent Technologies acquired iLab Solutions 8.1.3.4 Agilent Technologies and Eurofins Genomics Collaboration 8.1.3.5 Agilent Technologies and 10x Genomics Collaboration 8.1.3.6 EnzoBiochemInc’s patent infringement settlement with Agilent 8.1.3.7 Development and co-marketing agreement between Agilent Technologies and PureHoney Technologies 8.1.3.8 Agilent Technologies co-marketing agreement with Picometrics 8.2 Danaher Corporation 8.2.1 Danaher Corporation Mass Spectrometry Product Portfolio 8.2.2 Danaher Corporation: Financial Overview 8.2.3 Danaher Corporations Recent Developments: 8.2.3.1 Danaher’s Acquisition of Cepheid 8.2.3.2 Separation of Fortive Corporation 8.2.3.3 Acquisition of Pall 8.3 Dani Instruments S.P.A 8.3.1 Dani Instruments Mass Spectrometry Product Portfolio 8.3.2 Dani Instruments Recent Development 8.3.2.1 DANI Instruments will supply state-of-the-art FTIR Instrumentation to the Japan Police Department 8.3.2.2 DANI Instruments acquired Spectra Analysis Instruments 8.4 PerkinElmer 8.4.1 PerkinElmer Mass Spectroscopy Product Portfolio 8.4.2 PerkinElmer : Financial Overview 8.4.3 PerkinElmer: Recent Developments 8.4.3.1 Restructuring 8.4.3.2 PerkinElmer and Genome Institute of Singapore to Open Joint Research Laboratory 8.4.3.3 PerkinElmer sold its NTD Laboratory Services Business to Eurofins Scientific 8.4.3.4 PerkinElmer Acquires Vanadis Diagnostics 8.4.3.5 Acquisition of Ceiba Solutions 8.4.3.6 Launch of Qsight Triple Quadrapole LC/MS/MS system 8.5 Shimadzu Corporation 8.5.1 Shimadzu Corporation: Mass spectroscopy Portfolio 8.5.2 Shimadzu Corporation: Financial Analysis 8.5.3 Shimadzu Corporation: Recent Developments 8.5.3.1 Establishment of a sales company in Malaysia 8.5.3.2 Shimadzu’s new GCMS-TQ8050 Mass Spectrometer offers world’s highest sensitivity 8.5.3.3 New mass spectrometry center in China 8.5.3.4 Acquisition of local distributor to mark presence in Latin American region 8.5.3.5 Expansion of product portfolio by the launch of GCMS-TQ8050 mass spectrometer 8.6 Thermo Fisher Scientific 8.6.1 Thermo Fisher : Mass Spectrometry Product Portfolio 8.6.2 Thermo Fisher: Financial Overview 8.6.3 Thermo Fisher: Recent Development 8.6.3.1 The company expands its Fisher Bio Services cryogenic service capabilities in Japan 8.6.3.2 Thermo Fisher partnered with Hamilton Bonaduz AG to provide Automation Platforms Access for Forensic Customers 8.6.3.3 Thermo Fisher strengthens its bioproduction product portfolio 8.6.3.4 Thermo Fisher Acquired Alfa Aesar 8.6.3.5 Thermo Fisher Completes Acquisition of Affymetrix 8.6.3.6 Approval of three products in EU resulting in strengthening the portfolio of the company 8.6.3.7 Launch of Gas Chromatography-mass spectrometry (GC-MS) 8.6.4 Thermo Fisher Scientific: Products in Development 8.6.4.1 Thermo FisherSubmits Premarket Approval Application for Universal, Next-Generation Sequencing-Based Oncology Test 8.7 Bruker Corporation 8.7.1 Bruker Corporation Mass Spectrometry Product Portfolio 8.7.2 Bruker Corporation: Financial Overview 8.7.3 Bruker Corporation: Recent Development 8.7.3.1 Bruker Acquired Preclinical PET imaging Business: 8.7.3.2 Bruker Acquired Jordan Valley Semiconductors, Ltd. 8.7.3.3 Acquisition of Active Spectrum Inc manufacturer of mass spectroscopy system 8.7.3.4 Product launches to strengthen the company portfolio and the market presence 8.7.4 Bruker Corporation: Products in Development 8.7.4.1 Contour CMM™ Dimensional Analysis System: 8.8 Waters Corporation 8.8.1 Waters Corporation: Mass Spectrometry Product Portfolio 8.8.2 Waters Corporation: Financial Analysis 8.8.3 Waters Corporation Recent Developments 8.8.3.1 Waters and SOTAX group signed Co-marketing and Re-seller agreement 8.8.3.2 The Waters ACQUITY Arc System Receives Frost & Sullivan New Product Innovation Award 8.8.3.3 New technological development and launch five new products 8.8.4 Waters Corporation New Product Development 8.8.4.1 Waters and BTI will develop methods of finding cancer markers 8.9 LECO Corporation 8.9.1 LECO Corporation Mass Spectrometry Product Portfolio 8.9.2 LECO Corporation Recent Developments 8.9.2.1 LECO Corporation established new application and technology center in Berlin 8.9.2.2 LECO Introduced Sulfur Configuration for Macro Elemental Sample Analysis 8.10 Protea Biosciences 8.10.1 Protea Biosciences Mass Spectrometry Product Portfolio 8.10.2 Protea Biosciences: Financial Overview 8.10.3 Protea Biosciences: Recent Development 8.10.3.1 Protea collaborated with Agilent Technologies, Inc. to address Biopharm workflow challenges 8.10.3.2 Protea is focusing to bring innovative products in the market to cover untapped areas
9. Conclusions and Recommendations 9.1 The Global Mass Spectrometry Market in 2016 and 2017 9.1.1 Current Leading Mass Spectrometry Segments 9.1.2 Leading Mass Spectrometry Companies 9.1.3 Leading Regional Markets 9.2 The Global Mass Spectrometry Market in 2016-2027 9.3 The Future of the Mass Spectrometry Market
10. Glossary Associated Visiongain Reports Visiongain Report Sales Order Form Appendix A About Visiongain Appendix B Visiongain report evaluation form
List of Figures Figure 2.1 Global Mass Spectrometry Market Segmentation Overview Figure 2.2 Electron Ionisation Source Diagram Figure 4.1 Global Mass Spectrometry by Technology Forecast 2016-2027 ($bn, Global AGR %) Figure 4.2 Global Mass Spectrometry by Technology: Market Shares (%), 2016 Figure 4.3 Global Mass Spectrometry by Technology: Market Shares Forecast 2021 (% Share) Figure 4.4 Global Mass Spectrometry by Technology: Market Shares Forecast 2027 (% Share) Figure 4.5 Global Ion Trap Mass Spectrometry Forecast 2016-2027 ($bn, AGR %) Figure 4.6 Global Quadrupole Mass Spectrometry Forecast 2016-2027 ($bn, AGR %) Figure 4.7 Global Time-of-Flight Mass Spectrometry Forecast 2016-2027 ($bn, AGR %) Figure 4.8 Global Single Mass Spectrometry by Type Market AGR Forecast 2016-2026 (AGR %) Figure 4.9 Global Single Mass Spectrometry Market Share by Regions Market Forecast 2016 (% Share) Figure 4.10 Global Single Mass Spectrometry Market Share by Regions Market Forecast 2021 (% Share) Figure 4.11 Global Single Mass Spectrometry Market Share by Regions Market Forecast 2027 (% Share) Figure 4.12 Global Triple Quadrupole Mass Spectrometry Forecast 2016-2027 ($bn, AGR %) Figure 4.13 Global Quadrupole TOF Mass Spectrometry Forecast 2016-2027 ($bn, AGR %) Figure 4.14 Global Fourier Transform Mass Spectrometry Forecast 2016-2027 ($bn, AGR %) Figure 4.15 Hybrid Mass Spectrometry by Type Market AGR Forecast 2016-2027 (AGR %) Figure 4.16 Global Hybrid Mass Spectrometry Market Share by Regions Market Forecast 2016 (% Share) Figure 4.17 Global Hybrid Mass Spectrometry Market Share by Regions Market Forecast 2021 (% Share) Figure 4.18 Global Hybrid Mass Spectrometry Market Share by Regions Market Forecast 2027 (% Share) Figure 5.1 Global Mass Spectrometry by Application Forecast 2016-2027 ($bn, Global AGR %) Figure 5.2 Global Mass Spectrometry by Application: Market Shares (%), 2021 Figure 5.3 Global Mass Spectrometry by Application: Market Shares (%), 2027 Figure 5.4 Global Academia Mass Spectrometry Forecast 2016-2027 ($bn, AGR %) Figure 5.5 Global Biotech and Biopharma Mass Spectrometry Forecast 2016-2027 ($bn, AGR %) Figure 5.6 Global Agriculture Mass Spectrometry Forecast 2016-2027 ($bn, AGR %) Figure 5.7 Global Contract Research Organizations Mass Spectrometry Forecast 2016-2027 ($bn, AGR %) Figure 5.8 Global Hospitals/Clinical Laboratories Mass Spectrometry Forecast 2016-2027 ($bn, AGR %) Figure 5.9 Global Environmental Industry Mass Spectrometry Forecast 2016-2027 ($bn, AGR %) Figure 5.10 Global Material Mass Spectrometry Forecast 2016-2027 ($bn, AGR %) Figure 6.1 North America Mass Spectrometry Market Forecast: Revenues ($bn) and AGR (%), 2016-2027 Figure 6.2 North America Mass Spectrometry Market: Market Shares (%) by National Market, 2016 Figure 6.3 North America Mass Spectrometry Market: Market Shares (%) by National Market, 2020 Figure 6.4 North America Mass Spectrometry Market: Market Shares (%) by National Market, 2027 Figure 6.5 US Mass Spectrometry Market Forecast: Revenues ($bn) and AGR (%), 2016-2027 Figure 6.6 Canada Mass Spectrometry Market Forecast: Revenues ($bn) and AGR (%), 2016-2027 Figure 6.7 European Mass Spectrometry Market Forecast: Revenues ($bn) and AGR (%), 2016-2027 Figure 6.8 European Mass Spectrometry Market: Market Shares (%) by National Market, 2016 Figure 6.9 European Mass Spectrometry Market: Market Shares (%) by National Market, 2020 Figure 6.10 European Mass Spectrometry Market: Market Shares (%) by National Market, 2027 Figure 6.11 German Mass Spectrometry Market Forecast: Revenues ($bn) and AGR (%), 2016-2027 Figure 6.12 French Mass Spectrometry Market Forecast: Revenues ($bn) and AGR (%), 2016-2027 Figure 6.13 UK Mass Spectrometry Market Forecast: Revenues ($bn) and AGR (%), 2016-2027 Figure 6.14 Italian Mass Spectrometry Market Forecast: Revenues ($bn) and AGR (%), 2016-2027 Figure 6.15 Spanish Mass Spectrometry Market Forecast: Revenues ($bn) and AGR (%), 2016-2027 Figure 6.16 APAC Mass Spectrometry Market Forecast: Revenues ($bn) and AGR (%), 2016-2027 Figure 6.17 APAC Mass Spectrometry Market: Market Shares (%) by National Market, 2016 Figure 6.18 APAC Mass Spectrometry Market: Market Shares (%) by National Market, 2020 Figure 6.19 APAC Mass Spectrometry Market: Market Shares (%) by National Market, 2027 Figure 6.20 Japanese Mass Spectrometry Market Forecast: Revenues ($bn) and AGR (%), 2016-2027 Figure 6.21 Chinese Mass Spectrometry Market Forecast: Revenues ($bn) and AGR (%), 2016-2027 Figure 6.22 Indian Mass Spectrometry Market Forecast: Revenues ($bn) and AGR (%), 2016-2027 Figure 6.23 Australia & New Zealand Mass Spectrometry Market Forecast: Revenues ($bn) and AGR (%), 2016-2027
List of Tables Table 1.1 Leading National Mass Spectrometry Market Forecast by National 2016-2027 ($m, AGR %, Cumulative) Table 3.1 Global Mass Spectrometry Market Forecast 2016-2027 (US$bn, AGR %, CAGR %) Table 4.1: Global Mass Spectrometry by Technology Forecast 2016-2027 ($bn, AGR %, CAGR %) Table 4.2 Global Mass Spectrometry by Technology by Regional Market Forecast 2016-2027 ($bn, Cumulative, Global AGR %) Table 4.3 Global Mass Spectrometry Technology, CAGR Forecast 2016-2021, 2021-2027, 2016-2026 (CAGR %) Table 4.4 Global Ion Trap Mass Spectrometry Market Forecast 2016-2027 ($bn, AGR %, CAGR %) Table 4.5 Global Quadrupole Mass Spectrometry Market Forecast 2016-2027 ($bn, AGR %, CAGR %) Table 4.6 Global Time-of-Flight Market Forecast 2016-2027 ($bn, AGR %, CAGR %) Table 4.7 Global Single Mass Spectrometry by Type Market Forecast 2016-2026 ($bn, AGR %, CAGR %) Table 4.8 Global Triple Quadrupole Mass Spectrometry Market Forecast 2016-2027 ($bn, AGR %, CAGR %) Table 4.9 Global Quadrupole TOF Mass Spectrometry Market Forecast 2016-2027 ($bn, AGR %, CAGR %) Table 4.10 Global Fourier Transform Mass Spectrometry Market Forecast 2016-2027 ($bn, AGR %, CAGR %) Table 4.11 Global Hybrid Mass Spectrometry by Type Market Forecast 2016-2026 ($bn, AGR %, CAGR %) Table 5.1 Global Mass Spectrometry by Applications Forecast 2016-2027 ($bn, AGR %, CAGR %) Table 5.1 Global Mass Spectrometry by Applications Forecast 2016-2027 ($bn, AGR %, CAGR %) (continued) Table 5.2 Global Mass Spectrometry by Applications by Regional Market Forecast 2016-2027 ($bn, Cumulative, Global AGR %) Table 5.2 Global Mass Spectrometry by Applications by Regional Market Forecast 2016-2027 ($bn, Cumulative, Global AGR %) (continued) Table 5.3 Global Academia Mass Spectrometry Market Forecast 2016-2027 ($bn, AGR %, CAGR %) Table 5.4 Global Biotech and Biopharma Mass Spectrometry Market Forecast 2016-2027 ($bn, AGR %, CAGR %, Cumulative) Table 5.5 Global Agriculture Mass Spectrometry Market Forecast 2016-2027 ($bn, AGR %, CAGR %) Table 5.6 Global Contract Research Organizations Mass Spectrometry Market Forecast 2016-2027 ($bn, AGR %, CAGR %) Table 5.7 Global Hospitals/Clinical Laboratories Mass Spectrometry Market Forecast 2016-2027 ($bn, AGR %, CAGR %) Table 5.8 Global Environmental Industry Mass Spectrometry Market Forecast 2016-2027 ($bn, AGR %, CAGR %, Cumulative) Table 5.9 Global Material Mass Spectrometry Market Forecast 2016-2027 ($bn, AGR %, CAGR %, Cumulative) Table 6.1 Global Mass Spectrometry Market by Region: Revenues (US$bn) and Market Share (%), 2016 and 2017 Table 6.2 Mass Spectrometry Market by Region Forecast 2016-2027 (US$bn, AGR %, CAGR %) Table 6.3 North America Mass Spectrometry Market Forecast 2016-2027 (US$bn, AGR %, CAGR %) Table 6.4 US Mass Spectrometry Market Forecast 2016-2027 (US$bn, AGR %, CAGR %) Table 6.5 Canada Mass Spectrometry Market Forecast 2016-2027 (US$bn, AGR %, CAGR %) Table 6.6 European Mass Spectrometry Market Forecast 2016-2027 (US$bn, AGR %, CAGR %) Table 6.7 German Mass Spectrometry Market Forecast 2016-2027 (US$bn, AGR %, CAGR %) Table 6.8 French Mass Spectrometry Market Forecast 2016-2027 (US$bn, AGR %, CAGR %) Table 6.9 UK Mass Spectrometry Market Forecast 2016-2027 (US$bn, AGR %, CAGR %) Table 6.10 Italian Mass Spectrometry Market Forecast 2016-2027 (US$bn, AGR %, CAGR %) Table 6.11 Spanish Mass Spectrometry Market Forecast 2016-2027 (US$bn, AGR %, CAGR %) Table 6.12 APAC Mass Spectrometry Market Forecast 2016-2027 (US$bn, AGR %, CAGR %) Table 6.13 Japanese Mass Spectrometry Market Forecast 2016-2027 (US$bn, AGR %, CAGR %) Table 6.14 Chinese Mass Spectrometry Market Forecast 2016-2027 (US$bn, AGR %, CAGR %) Table 6.15 Indian Mass Spectrometry Market Forecast 2016-2027 (US$bn, AGR %, CAGR %) Table 6.16 Australia & New Zealand Mass Spectrometry Market Forecast 2016-2027 (US$bn, AGR %, CAGR %) Table 8.1 Agilent Technologies, Overview, 2016 Table 8.2 Agilent Technologies: Life Sciences and Applied Market Revenue 2016-2027 (US$bn, AGR %, CAGR %) Table 8.3 Danaher Corporation, Overview, 2016 Table 8.4 Danaher Corporation: Life Sciences and Diagnostics Revenue 2016-2027 (US$bn, AGR %, CAGR %) Table 8.5 Dani Instruments S.P.A, Overview, 2016 Table 8.6 PerkinElmer Overview, 2016 Table 8.7 Perkin Elmer: Environmental Health Revenue 2016-2027 (US$bn, AGR %, CAGR %) Table 8.8 Shimadzu Corporation, Overview, 2016 Table 8.10 Shimadzu Corporation: Analytical and Measuring Instruments Revenue (US$bn, AGR %, CAGR %) Table 8.11 Thermo Fisher Overview, 2016 Table 8.12 Thermo Fisher: Analytical Instruments Revenue (US$bn, AGR %, CAGR %) Table 8.13 Bruker Corporation Overview, Overview, 2016 Table 8.14 Bruker Corporation: CALID Revenue (US$bn, AGR %, CAGR %) Table 8.15 Waters Corporation, Overview, 2016 Table 8.16 Waters Corporation: Instruments Systems Revenue ($bn), AGR(%), CAGR(%), 2016-2027 Table 8.17 LECO Corporation, Overview, 2016 Table 8.18 Protea Biosciences Overview, 2016 Table 8.19 Protea Biosciences: Molecular information services Revenue ($bn), AGR(%), CAGR(%), 2016-2027
ABB Bomem Buchi Kinemed Molecular Imaging MR Solutions Nikon Oxford Instruments PANalytical Prosolia Renishaw RS2D Shimadzu Corporation Trifoil Zeiss 10X Genomics Abbott Laboratories Affymetrix Agilent Technologies Alfa Aesar Ametek’sSpectro Analytik Jena Anton-Paar GmbH Aurochemicals Australian Medical Research Future Fund Beckman Coulter Biocrates Bioprocessing Technology Institute Bruker Corporation Burning Rock Ceiba Solutions Center for Devices and Radiological Health Cepheid Copper Merger Sub, Inc Danaher Corporation Dani Instruments Edax divisions EnzoBiochem Eurofins Scientific European Commission Food and Drug Administration Fortive Foss Frost & Sullivan GE healthcare General Electric Company Genome Institute Harvard Bioscience Hitachi iLab Solutions LLC Imabiotech Institutional Review Board Jasco JEOL Johnson Mathey Plc LECO Corporation Malvern Instruments Ltd. Materlab Mediso Mettler-Toledo Mettler-Toledo International Inc. Michigan State University NantHealth NETZSCH-Geraetebau GmbH NHS Olympus Omic Sciences Pall Life Sciences PerkinElmer Philips Picometrics Technologies Protea Biosciences PureHoney technologies Rigaku Smiths Detection Sorgente Sotex Group Spain’s Centre for Omic Sciences Syntech Techcomp Thermo Fisher Scientific Unternehmensverband Life Sciences Bremenis Vanadis Diagnostics Veeda Clinical Research Visualsonics (Fuji Film) Waters Corporation
Download sample pages
Complete the form below to download your free sample pages for The Mass Spectrometry Market Forecast 2017-2027
Download sample pages
Complete the form below to download your free sample pages for The Mass Spectrometry Market Forecast 2017-2027
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
